Nanotheranostics for Cancer Applications

• Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
• Άλλοι συγγραφείς: Rai, Prakash (Επιμελητής έκδοσης, http://id.loc.gov/vocabulary/relators/edt), Morris, Stephanie A. (Επιμελητής έκδοσης, http://id.loc.gov/vocabulary/relators/edt)
• Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
• Γλώσσα: English
• Έκδοση: Cham : Springer International Publishing : Imprint: Springer, 2019.
• Έκδοση: 1st ed. 2019.
• Σειρά: Bioanalysis, Advanced Materials, Methods, and Devices, 5
• Θέματα: Biomedical engineering.; Oncology .; Nanochemistry.; Biomaterials.; Pharmaceutical technology.; Biophysics.; Biological physics.; Biomedical Engineering and Bioengineering.; Oncology.; Pharmaceutical Sciences/Technology.; Biological and Medical Physics, Biophysics.

This book is the first to focus specifically on cancer nanotheranostics. Each of the chapters that make up this comprehensive volume is authored by a researcher, clinician, or regulatory agency member known for their expertise in this field. Theranostics, the technology to simultaneously diagnose an...

Πίνακας περιεχομένων:

• About the Editors
• List of Contributors
• Part I Introduction to Cancer and Nanotechnology
• 1 Introduction
• 2 Biological Events and Barriers to Effective Delivery of Cancer Therapeutics
• 3 Cancer Diagnostics and Therapeutics
• 4 Nanomedicine in Cancer
• 5 Theranostics: A Historical Perspective of Cancer Nanotechnology Paving the Way for Simultaneous Use Applications
• Part II Cancer Nanodiagnostics and Nanotherapeutics
• 6 In Vitro Cancer Diagnostics
• 7 Translational Nanodiagnostics for In Vivo Cancer Detection
• 8 Delivery of Cancer Nanotherapeutics
• 9 Oral Nanotherapeutics for Cancer with Innovations in Lipid and Polymeric Nanoformulations
• 10 Topical and Transdermal Nanomedicines for Cancer Therapy
• 11 Cancer Nanotherapeutics Administered by Non-Conventional Routes
• Part III Regulatory Considerations for Nanomaterial Drug Products
• 12 Regulatory Considerations for Cancer Drug Products Containing Nanomaterials
• 13 Perspectives for Characterizing Drug Component of Theranostic Products Containing Nanomaterials
• Part IV Cancer Nanotheranostics
• 14 Engineering Multifunctional Nanomedicine Platforms for Drug Delivery and Imaging
• 15 Image-Guided Drug Delivery
• 16 Nanotheranostics-Based Imaging for Cancer Treatment Monitoring
• 17 Remotely-Triggered Nanotheranostics
• 18 Concluding Remarks and the Future of Nanotheranostics
• Index.